Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced its official launch and completion of $82 million in seed and Series A financing to ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

High-performance computing, artificial intelligence, and quantum computing are transforming scientific research, enabling breakthroughs in drug discovery, climate modeling, and materials science. But ...

Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest. A ...

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...